100% agree with these comments. The market cap has always been built on a backbone of IP. It’s the accumulation of robust science that will drive the price.
The “chicken little” attitudes and hourly chartists completely miss what has been achieved and the big re-rate that’s coming. IHL is going to get gobbled up by the US market and if one of these trials deliver efficacy it will absolutely launch IMO.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-6823
-
-
- There are more pages in this discussion • 13,193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online